EA201600248A1 - Антибактериальные производные 2h-индазола - Google Patents

Антибактериальные производные 2h-индазола

Info

Publication number
EA201600248A1
EA201600248A1 EA201600248A EA201600248A EA201600248A1 EA 201600248 A1 EA201600248 A1 EA 201600248A1 EA 201600248 A EA201600248 A EA 201600248A EA 201600248 A EA201600248 A EA 201600248A EA 201600248 A1 EA201600248 A1 EA 201600248A1
Authority
EA
Eurasian Patent Office
Prior art keywords
indazol
antibacterial derivatives
antibacterial
derivatives
halogen
Prior art date
Application number
EA201600248A
Other languages
English (en)
Other versions
EA031562B1 (ru
Inventor
Жан-Кристоф Говен
Азели Мирре
Этьенн Ошала
Жан-Филипп Сюриве
Original Assignee
Актелион Фармасьютиклз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Актелион Фармасьютиклз Лтд. filed Critical Актелион Фармасьютиклз Лтд.
Publication of EA201600248A1 publication Critical patent/EA201600248A1/ru
Publication of EA031562B1 publication Critical patent/EA031562B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/65031Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)

Abstract

Изобретение относится к антибактериальным соединениям формулы Iв которой Rозначает Н или галоген; Rозначает алкинилокси или группу М; Rозначает Н или галоген; М означает одну из группв которой А означает связь, СНСН, СН=СН или С≡С и R, R, R, Rи Rявляются такими как определено в п.1 формулы изобретения; и его солям.
EA201600248A 2013-09-13 2014-09-12 Антибактериальные производные 2h-индазола EA031562B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013058537 2013-09-13
PCT/IB2014/064458 WO2015036964A1 (en) 2013-09-13 2014-09-12 Antibacterial 2h-indazole derivatives

Publications (2)

Publication Number Publication Date
EA201600248A1 true EA201600248A1 (ru) 2016-08-31
EA031562B1 EA031562B1 (ru) 2019-01-31

Family

ID=51688371

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201600248A EA031562B1 (ru) 2013-09-13 2014-09-12 Антибактериальные производные 2h-индазола

Country Status (29)

Country Link
US (1) US9802901B2 (ru)
EP (1) EP3044211B1 (ru)
JP (1) JP6353909B2 (ru)
KR (1) KR20160055889A (ru)
CN (1) CN105531264B (ru)
AR (1) AR097617A1 (ru)
AU (1) AU2014319966B2 (ru)
BR (1) BR112016007757A8 (ru)
CA (1) CA2923146A1 (ru)
CL (1) CL2016000568A1 (ru)
CY (1) CY1120111T1 (ru)
DK (1) DK3044211T3 (ru)
EA (1) EA031562B1 (ru)
ES (1) ES2662894T3 (ru)
HR (1) HRP20180484T1 (ru)
HU (1) HUE038519T2 (ru)
IL (1) IL244500B (ru)
LT (1) LT3044211T (ru)
MA (1) MA38948B1 (ru)
MX (1) MX361733B (ru)
MY (1) MY179283A (ru)
PH (1) PH12016500480A1 (ru)
PL (1) PL3044211T3 (ru)
PT (1) PT3044211T (ru)
SG (1) SG11201601889YA (ru)
SI (1) SI3044211T1 (ru)
TW (1) TWI646084B (ru)
UA (1) UA116484C2 (ru)
WO (1) WO2015036964A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201605014YA (en) 2013-12-19 2016-07-28 Actelion Pharmaceuticals Ltd Antibacterial 1h-indazole and 1h-indole derivatives
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
EP3143007B1 (en) 2014-05-16 2018-07-11 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
TW201625569A (zh) 2014-11-19 2016-07-16 艾克泰聯製藥有限公司 抗菌性苯并噻唑衍生物
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AU2016314963A1 (en) * 2015-08-28 2018-04-19 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) * 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
MX2018014170A (es) * 2016-05-17 2019-03-14 Idorsia Pharmaceuticals Ltd Derivados 6-(buta-1,3-diin-1-il)benzo[d]tiazol.
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
CN113372276B (zh) * 2021-05-25 2022-04-22 三峡大学 吲唑类衍生物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370714A1 (en) 2001-12-05 2005-05-30 Ortho-Mcneil Pharmaceutical, Inc. 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials
US6806279B2 (en) 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
ES2407849T3 (es) 2002-03-13 2013-06-14 Array Biopharma, Inc. Derivados de bencimidazol alquilados N3 como inhibidores de MEK
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
BRPI0518984A2 (pt) 2004-12-10 2008-12-16 Univ Emory anÁlogos de nucleosÍdeo de ciclobutil substituÍdos em 2' e 3' para tratamento de infecÇÕes virais e proliferaÇço celular anormal
PL1863818T3 (pl) 2005-03-23 2010-08-31 Hoffmann La Roche Pochodne acetylenylo-pirazolo-pirymidyny jako antagoniści MGLUR2
ES2602615T3 (es) 2007-06-12 2017-02-21 Achaogen, Inc. Agentes antibacterianos
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
WO2010135536A2 (en) 2009-05-20 2010-11-25 Ardea Biosciences, Inc. Methods of modulating uric acid levels
US20120101099A1 (en) 2009-07-07 2012-04-26 Anthem Biosciences Private Limited Histone deacetylase inhibitors
CA2774250C (en) * 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
CA2782453C (en) 2009-12-16 2015-11-24 Matthew Frank Brown N-linked hydroxamic acid derivatives useful as antibacterial agents
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
JP2014501716A (ja) 2010-11-10 2014-01-23 アカオジェン インコーポレイテッド ヒドロキサム酸誘導体および細菌感染の処置におけるその使用
EP2661438A4 (en) 2011-01-03 2014-06-11 Hanmi Pharm Ind Co Ltd NEW BICYCLIC COMPOUND FOR THE MODULATION OF G PROTEIN-COUPLED RECEPTORS
SG192766A1 (en) * 2011-03-07 2013-09-30 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
EP2694481B1 (en) * 2011-04-08 2015-12-30 Pfizer Inc Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
SG193367A1 (en) 2011-04-08 2013-10-30 Pfizer Isoxazole derivatives useful as antibacterial agents
EP2847162A1 (en) 2012-05-09 2015-03-18 Achaogen, Inc. Antibacterial agents
SG11201605014YA (en) 2013-12-19 2016-07-28 Actelion Pharmaceuticals Ltd Antibacterial 1h-indazole and 1h-indole derivatives
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
EP3143007B1 (en) 2014-05-16 2018-07-11 Idorsia Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives

Also Published As

Publication number Publication date
MX361733B (es) 2018-12-14
PT3044211T (pt) 2018-03-21
IL244500A0 (en) 2016-04-21
EP3044211A1 (en) 2016-07-20
JP2016530327A (ja) 2016-09-29
AR097617A1 (es) 2016-04-06
IL244500B (en) 2018-05-31
CN105531264B (zh) 2018-04-10
AU2014319966A1 (en) 2016-05-05
US20160221959A1 (en) 2016-08-04
PL3044211T3 (pl) 2018-06-29
CL2016000568A1 (es) 2016-11-11
UA116484C2 (uk) 2018-03-26
KR20160055889A (ko) 2016-05-18
MA38948B1 (fr) 2018-04-30
EP3044211B1 (en) 2018-01-03
EA031562B1 (ru) 2019-01-31
MA38948A1 (fr) 2017-05-31
PH12016500480B1 (en) 2016-05-16
TWI646084B (zh) 2019-01-01
BR112016007757A8 (pt) 2018-08-14
MY179283A (en) 2020-11-03
HRP20180484T1 (hr) 2018-05-04
SG11201601889YA (en) 2016-04-28
JP6353909B2 (ja) 2018-07-04
CN105531264A (zh) 2016-04-27
AU2014319966B2 (en) 2018-11-15
CA2923146A1 (en) 2015-03-19
BR112016007757A2 (pt) 2018-07-10
ES2662894T3 (es) 2018-04-10
HUE038519T2 (hu) 2018-10-29
SI3044211T1 (en) 2018-04-30
TW201542531A (zh) 2015-11-16
DK3044211T3 (en) 2018-03-12
MX2016003196A (es) 2016-06-02
PH12016500480A1 (en) 2016-05-16
LT3044211T (lt) 2018-04-10
WO2015036964A1 (en) 2015-03-19
US9802901B2 (en) 2017-10-31
CY1120111T1 (el) 2018-12-12

Similar Documents

Publication Publication Date Title
EA201600248A1 (ru) Антибактериальные производные 2h-индазола
EA201691775A1 (ru) Производные 1,2-дигидро-3н-пирроло[1,2-с]имидазол-3-она и их применение в качестве антибактериальных средств
EA201991198A1 (ru) АМИНОТИАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201691085A1 (ru) Замещенные бензамиды и способы их применения
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA201991197A1 (ru) БЕНЗИМИДАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit
EA201591491A1 (ru) Соединения тетрагидропирролотиазина
BR112018003343A2 (pt) compostos heteroarila como inibidores de irak e usos dos mesmos
EA201890626A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНОВЫЕ АНТИБАКТЕРИАЛЬНЫЕ СОЕДИНЕНИЯ
BR112018003812A2 (pt) compostos de heteroarila como inibidores de irak e usos dos mesmos
EA201592126A1 (ru) 6-мостиковые гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
EA201591457A1 (ru) Терапевтические соединения
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
EA201792021A1 (ru) Ингибитор jak
EA201591360A1 (ru) Азабензимидазолы в качестве ингибиторов изозимов фдэ4 для лечения цнс и других расстройств
BR112015018509A2 (pt) compostos de imidazo piridina
EA201690844A1 (ru) Ингибиторы gsk-3
EA201591122A1 (ru) Гетероциклическое соединение
EA201692521A1 (ru) Пиразольные соединения и их применение в качестве блокаторов кальциевых каналов т-типа
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201690911A1 (ru) Соединения диметилбензойной кислоты
EA201891666A1 (ru) Арилзамещенные пиримидины для применения при инфекции, вызванной вирусом гриппа

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU